Singapore markets closed

Emmaus Life Sciences, Inc. (EMMA)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.09210.0000 (0.00%)
At close: 10:43AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-17,687
-10,625
-15,946
1,354
-54,842
Depreciation & amortisation
55
53
59
60
73
Deferred income taxes
-
-
0
-427
0
Stock-based compensation
18
16
553
739
3,805
Change in working capital
2,971
2,209
2,110
-3,968
311
Accounts receivable
1,139
607
-845
1,953
-361
Inventory
448
434
462
-245
-3,267
Other working capital
-5,965
-5,099
-1,327
-2,466
-4,583
Other non-cash items
1,758
2,067
2,310
4,027
27,122
Net cash provided by operating activities
-5,885
-5,073
-1,254
-2,451
-4,523
Cash flows from investing activities
Investments in property, plant and equipment
-80
-26
-73
-15
-60
Acquisitions, net
-
-
-
0
-1,645
Purchases of investments
-
-
0
-26,160
0
Sales/maturities of investments
2,919
2,919
0
35,601
221
Other investing activities
-5,289
-5,280
-6,304
-3,956
-
Net cash used for investing activities
-2,450
-2,387
-6,377
5,470
-1,484
Cash flows from financing activities
Debt repayment
-3,189
-3,135
-8,779
-5,217
-5,491
Common stock issued
-
-
0
142
8,589
Common stock repurchased
-
-
-
-
0
Net cash used provided by (used for) financing activities
7,263
7,233
7,411
-2,310
3,884
Net change in cash
-1,142
-258
-208
718
-2,136
Cash at beginning of period
2,321
2,279
2,487
1,769
3,905
Cash at end of period
1,249
2,021
2,279
2,487
1,769
Free cash flow
Operating cash flow
-5,885
-5,073
-1,254
-2,451
-4,523
Capital expenditure
-80
-26
-73
-15
-60
Free cash flow
-5,965
-5,099
-1,327
-2,466
-4,583